Stock listing

OTC:HRGN Harvard Apparatus Regenerative Technology Inc Stock

Follow Harvard Apparatus Regenerative Technology Inc into a list and get an email when it puts out news.

Share price · OTC:HRGN

$1.90 USD 0.00 (0.0%)

Close on Nov 20, 2026

Past year +2.7% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$1.90 – $1.90 USDNov 20, 2026
Volume
1,200 sharesNov 20, 2026
Market cap
$38.54M USDAt the close on Nov 20, 2026 · price × 20.28M shares outstanding
52-week range
$0.96 – $2.46 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$5,040 USDMedian day 950 shares · 12 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026
Harvard Apparatus Regenerative Technology Inc logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · OTC:HRGN · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$1.900.000.0%$1.90$1.90$1.901,200
$1.900.000.0%$1.92$1.92$1.902,200
$1.90-0.08-4.0%$1.90$1.90$1.9010,100
$1.98+0.17+9.4%$2.00$2.00$1.98500
$1.81-0.28-13.4%$2.01$2.01$1.814,920
$2.09+0.18+9.4%$2.09$2.10$2.0921,200
$1.91-0.39-17.0%$2.25$2.25$1.912,344
$2.300.000.0%$1.93$2.30$1.9314,537
$2.300.000.0%$2.45$2.45$2.30700
$2.30+0.14+6.5%$2.11$2.30$1.975,300
$2.16+0.20+10.2%$1.97$2.16$1.972,100
$1.960.000.0%$1.96$1.96$1.960
$1.96-0.002-0.1%$1.954$1.96$1.954900
$1.9620.000.0%$1.962$1.962$1.9620
$1.962-0.008-0.4%$1.962$1.962$1.962100
$1.97-0.09-4.4%$1.97$1.97$1.974,100
$2.06-0.14-6.4%$2.06$2.06$2.06200
$2.20-0.014-0.6%$2.161$2.20$2.1611,100
$2.214-0.016-0.7%$2.23$2.23$2.214700
$2.23-0.07-3.0%$2.22$2.23$2.22600
$2.30+0.05+2.2%$2.30$2.30$2.30800
$2.25+0.13+6.1%$2.14$2.25$2.143,500
$2.120.000.0%$2.12$2.12$2.120
$2.12-0.18-7.8%$2.12$2.12$2.12100
$2.300.000.0%$2.30$2.30$2.30100
$2.300.000.0%$2.33$2.33$2.303,300
$2.30+0.05+2.2%$2.25$2.30$2.252,100
$2.25+0.04+1.8%$2.22$2.25$2.221,450
$2.21+0.02+0.9%$2.25$2.25$2.211,406
$2.19-0.01-0.5%$2.19$2.205$2.191,200
$2.200.000.0%$2.20$2.20$2.200
$2.20+0.05+2.3%$2.16$2.21$2.151,000
$2.150.000.0%$2.15$2.15$2.150
$2.15+0.18+9.1%$2.00$2.15$2.001,300
$1.97-0.003-0.2%$2.00$2.00$1.977,100
$1.973-0.06-3.0%$1.98$1.98$1.973300
$2.033+0.223+12.3%$2.033$2.033$2.033400
$1.81-0.49-21.3%$1.81$1.81$1.811,100
$2.30+0.05+2.2%$2.20$2.30$2.201,600
$2.25-0.10-4.3%$2.25$2.25$2.252,328
$2.35+0.05+2.2%$2.35$2.35$2.351,617
$2.300.000.0%$2.30$2.30$2.301,100
$2.30+0.34+17.3%$2.00$2.30$2.005,600
$1.960.000.0%$1.96$1.96$1.960
$1.960.000.0%$1.96$1.96$1.960
$1.96-0.216-9.9%$1.96$1.96$1.959,800
$2.1760.000.0%$2.176$2.176$2.1760
$2.176-0.174-7.4%$2.176$2.176$2.176700
$2.350.000.0%$2.35$2.35$2.350
$2.35+0.05+2.2%$2.30$2.463$2.226,500
$2.30+0.78+51.3%$1.58$2.40$1.5812,500
$1.52-0.06-3.8%$1.52$1.52$1.52100
$1.580.000.0%$1.58$1.58$1.580
$1.58-0.008-0.5%$1.58$1.58$1.58400
$1.5880.000.0%$1.588$1.588$1.58826
$1.588+0.069+4.5%$1.56$1.588$1.561,100
$1.5190.000.0%$1.519$1.519$1.5190
$1.5190.000.0%$1.519$1.519$1.5190
$1.5190.000.0%$1.519$1.519$1.51950
$1.519+0.119+8.5%$1.519$1.519$1.519700

Splits

1 split · OTC:HRGN · every price before a split is adjusted for it

DayRatioWhat
1-for-20Consolidation
Ticker
OTC:HRGN
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
OTC
Currency
USD

Harvard Apparatus Regenerative Technology Inc on 6ix

Sector
Health care
Industry
Biotechnology
Decks
2 decks · latest September 2023

Valuation

EV/sales 36.5× against a median of 26.0×: 7th lowest of 9 Biotechnology companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$36.69M USD
P/E
Loss
EV/sales
36.5×
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
73.8×
Gross margin
7.5%
Operating margin
−643.0%
Net margin
−642.0%
Debt to equity
0.0×
Beta vs S&P 500
0.09

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Harvard Apparatus Regenerative Technology Inc · OTC:HRGNUS$38.54MUS$36.69Mn/a36.5×n/a73.8×−642.0%0.0×0.09
Dogwood Therapeutics, Inc. · NASDAQ:DWTXUS$39.57MUS$34.74Mn/a347×n/a0.6×n/a0.0×0.79
Herantis Pharma PLC · OMXHEX:HRTISUS$38.69MUS$38.62Mn/an/an/an/an/an/an/a
Quratis Inc. · KRX:348080US$38.60MUS$29.66Mn/a36.2×n/a1.1×n/a0.0×n/a
KoBioLabs, Inc. · KRX:348150US$38.47MUS$7.00Mn/a0.1×n/a1.8×−6.4%0.2×n/a
OSE Immunotherapeutics SA · EURONEXT:OSEUS$38.31MUS$52.28Mn/a18.2×n/a1.3×n/a1.3×n/a
Sprint Bioscience AB · OMXSTO:SPRINTUS$37.98MUS$28.86M5.1×2.1×3.7×4.3×54.4%0.0×n/a
Theralase Technologies Inc. · TSXV:TLTUS$37.89MUS$34.22Mn/a61.1×n/a7.9×−472.5%0.0×0.75
Connect Biopharma Holdings Limited · NASDAQ:CNTBUS$37.15MUS$18.16Mn/a4.9×n/a3.1×n/a0.0×0.93
Coiled Therapeutics PLC · LSE:COILUS$37.13MUS$30.46Mn/an/an/a0.6×n/a0.0×n/a
TaiRx, Inc. · TPEX:6580US$37.08MUS$28.62Mn/a33.8×n/a3.3×−793.3%0.0×n/a
Median of the othersUS$38.14MUS$30.06M5.1×26.0×3.7×1.8×−239.4%0.0×0.79

Team and board

Officers

OfficerRole
Jerry HeCEO
Joseph DamasioChief Financial Officer
Hong YuPresident
Shunfu HuVP of Business Development and Operations
William FodorChief Scientific Officer

Board

DirectorRole
Jerry HeCEO
David GreenDirector
Herman SanchezDirector
James ShmerlingDirector
Jason Jing ChenVice Chairman
Mao ZhangDirector
Ron PackardDirector
Ting LiDirector

Events

QuarterResultsShare move
Q1 2026May 18, 2026−6.7%
Q4 2025Feb 25, 2026+6.6%
Q3 2025Nov 28, 2025+8.8%
Q2 2025Aug 29, 2025−4.0%
Q1 2025May 12, 2025 · Before open0.0%
Q4 2024Mar 31, 20250.0%
Q3 2024Nov 11, 2024 · Before open−2.0%
Q2 2024Aug 13, 2024 · Before open0.0%
Q1 2024May 13, 2024 · After close0.0%
Q4 2023Mar 28, 2024 · After close+3.4%
All 20 quarters
QuarterResultsShare move
Q3 2023Nov 13, 2023 · Before open0.0%
Q2 2023Aug 14, 2023 · Before open0.0%
Q1 2023May 12, 2023 · After close+5.5%
Q4 2022Mar 30, 2023 · After close+4.9%
Q3 2022Nov 14, 2022+1.8%
Q2 2022Aug 4, 2022−7.4%
Q1 2022Apr 1, 2022+10.0%
Quarter to Sep 30, 2021Nov 15, 2021+15.0%
Quarter to Jun 30, 2021Aug 13, 2021−13.8%
Quarter to Mar 31, 2021May 24, 20210.0%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (September 2023)Investor deck19 slidesSeptember 2023
Investor Presentation (September 2023)Investor deck18 slidesSeptember 2023

Open Decks

IPO

Withdrawn on May 2, 2013. Filed with the SEC to go public on Dec 11, 2012.

Price range
US$10.00 to US$12.00 a share
Shares offered
1,700,000 shares of common stock
Offering size
US$17 million to US$20.4 million · Shares offered times the price range, worked out by 6ix
Underwriters' option
Up to 255,000 more shares
Underwriters
Summer Street Research Partners, Maxim Group LLC · In the order on the cover

Steps

StepWhen
Filed publiclyDec 11, 2012
Amended 5 timesNewest Mar 26, 2013
Filing withdrawnMay 2, 2013

Open IPO · From the cover of the amended prospectus (S-1/A) filed Mar 26, 2013

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue704.0K430.0K103.0K0000082.0K
Cost of revenue646.0K270.0K24.0K0116.0K
Gross profit58.0K160.0K79.0K0-34.0K
Research and development2.65M2.31M3.06M1.74M1.59M2.07M4.85M3.92M7.59M7.60M
Selling, general and administrative4.41M7.04M3.26M4.02M3.92M3.88M4.49M
Operating income-6.92M-7.73M-8.99M-6.15M-8.64M-5.33M-8.87M-7.84M-11.5M-12.1M
Depreciation and amortization5.00K14.0K35.0K52.0K107.0K184.0K214.0K261.0K413.0K454.0K
EBITDA-6.91M-7.71M-8.96M-6.10M-8.53M-5.14M-8.66M-7.58M-11.1M-11.7M
Interest expense8.00K38.0K14.0K9.00K
Income before tax-6.87M-7.73M-11.9M-11.6M
Income tax000000
Net income-6.87M-7.73M-8.95M-6.07M-7.98M-4.87M-8.33M-7.53M-11.9M-11.6M
Earnings per share, basic-0.42-0.52-0.67-0.55-0.79-0.55-1.21-1.69-6.63-14.49
Earnings per share, diluted-0.67-0.55-0.79-0.55-1.21-1.69-6.63-14.49

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents1.35M2.49M432.0K1.24M1.24M1.03M913.0K1.30M4.04M2.94M
Short-term investments1.20M
Receivables16.0K231.0K4.00K042.0K
Inventory16.0K80.0K50.0K0
Current assets1.83M3.23M783.0K1.59M1.59M1.68M1.41M2.15M4.41M3.49M
Property, plant and equipment6.00K11.0K25.0K49.0K110.0K217.0K394.0K479.0K632.0K1.06M
Total assets2.68M4.44M2.61M2.40M1.87M2.08M1.99M2.63M5.04M4.55M
Accounts payable454.0K452.0K445.0K682.0K676.0K31.0K241.0K160.0K923.0K962.0K
Current liabilities1.53M1.02M968.0K1.36M4.84M756.0K814.0K662.0K1.62M2.78M
Total liabilities1.62M1.22M968.0K1.41M4.89M951.0K903.0K662.0K1.62M2.78M
Shareholders' equity1.06M3.22M1.65M-3.19M-3.03M1.13M1.09M1.97M3.42M1.77M
Shares outstanding17.6M15.9M13.9M12.2M10.8M9.39M8.16M5.67M2.51M855.4K

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-3.83M-4.85M-6.94M-5.11M-2.63M-4.04M-6.06M-7.64M-11.0M-9.06M
Capital spending0-11.0K-5.00K0-7.00K-129.0K-131.0K-136.0K-302.0K
Free cash flow-4.85M-6.95M-5.11M-2.63M-4.05M-6.19M-7.77M-11.2M-9.36M
Cash from investing0-11.0K-5.00K0-7.00K-129.0K-67.0K-136.0K-302.0K
Cash from financing2.70M6.91M6.14M5.06M2.84M4.16M5.80M5.02M12.2M4.84M
Share buybacks0-42.0K0
Change in cash-1.13M2.05M-809.0K-51.0K216.0K113.0K-392.0K-2.68M1.10M-4.51M

Open Financials

Filings

FilingDateTypeFiled with
10-Q · Quarterly reportNov 13, 2026Quarterly reportSEC
4 · Change in ownershipSep 25, 2026Insider tradeSEC
8-K · Current reportSep 14, 2026Material contractSEC
DSep 14, 2026Other filingsSEC
10-Q · Quarterly reportAug 13, 2026Quarterly reportSEC
4 · Change in ownershipAug 11, 2026Insider tradeSEC
8-K · Current reportAug 3, 2026Material contractSEC
8-K/A · Current report, amendedAug 3, 2026Material contractSEC
8-K · Current reportJun 23, 2026Meeting outcomeSEC
10-Q · Quarterly reportMay 13, 2026Quarterly reportSEC
Show 200 filings
FilingDateTypeFiled with
8-K · Current reportApr 28, 2026Current reportSEC
DEF 14A · Proxy statementApr 23, 2026Meeting noticeSEC
8-K · Current reportApr 15, 2026Current reportSEC
10-K · Annual reportMar 19, 2026Annual reportSEC
DJan 6, 2026Other filingsSEC
8-K · Current reportJan 6, 2026Material contractSEC
4 · Change in ownershipDec 1, 2025Insider tradeSEC
10-Q · Quarterly reportNov 7, 2025Quarterly reportSEC
4 · Change in ownershipOct 1, 2025Insider tradeSEC
4 · Change in ownershipSep 24, 2025Insider tradeSEC
4 · Change in ownershipSep 2, 2025Insider tradeSEC
10-Q · Quarterly reportAug 11, 2025Quarterly reportSEC
DJul 14, 2025Other filingsSEC
8-K · Current reportJul 14, 2025Material contractSEC
4 · Change in ownershipJul 1, 2025Insider tradeSEC
4 · Change in ownershipJul 1, 2025Insider tradeSEC
4 · Change in ownershipJul 1, 2025Insider tradeSEC
4 · Change in ownershipJul 1, 2025Insider tradeSEC
4 · Change in ownershipJul 1, 2025Insider tradeSEC
4 · Change in ownershipJul 1, 2025Insider tradeSEC
4 · Change in ownershipJul 1, 2025Insider tradeSEC
8-K · Current reportJun 24, 2025Meeting outcomeSEC
10-Q · Quarterly reportMay 14, 2025Quarterly reportSEC
DEF 14A · Proxy statementApr 29, 2025Meeting noticeSEC
PRE 14A · Preliminary proxy statementApr 17, 2025Meeting noticeSEC
8-K · Current reportApr 14, 2025Current reportSEC
10-K · Annual reportMar 31, 2025Annual reportSEC
CORRESP · Letter to the SECJan 6, 2025Other filingsSEC
4 · Change in ownershipJan 2, 2025Insider tradeSEC
UPLOAD · Letter from the SECDec 12, 2024Other filingsSEC
10-Q · Quarterly reportNov 13, 2024Quarterly reportSEC
8-K · Current reportNov 6, 2024Material contractSEC
4 · Change in ownershipSep 26, 2024Insider tradeSEC
3 · Initial statement of ownershipSep 26, 2024Insider tradeSEC
SC 13D · Big-stake noticeSep 26, 2024Big-stake noticeSEC
4 · Change in ownershipSep 12, 2024Insider tradeSEC
8-K · Current reportAug 27, 2024Management or board changeSEC
8-K · Current reportAug 21, 2024Material contractSEC
SC 13D/A · Big-stake notice, amendedAug 16, 2024Big-stake noticeSEC
10-Q · Quarterly reportAug 13, 2024Quarterly reportSEC
4 · Change in ownershipAug 7, 2024Insider tradeSEC
DAug 6, 2024Other filingsSEC
4 · Change in ownershipJul 15, 2024Insider tradeSEC
4 · Change in ownershipJul 15, 2024Insider tradeSEC
4 · Change in ownershipJul 15, 2024Insider tradeSEC
4 · Change in ownershipJul 15, 2024Insider tradeSEC
4 · Change in ownershipJul 15, 2024Insider tradeSEC
4 · Change in ownershipJul 15, 2024Insider tradeSEC
4 · Change in ownershipJul 2, 2024Insider tradeSEC
8-K · Current reportJun 24, 2024Meeting outcomeSEC
10-Q · Quarterly reportMay 13, 2024Quarterly reportSEC
DEF 14A · Proxy statementApr 29, 2024Meeting noticeSEC
8-K · Current reportApr 17, 2024Material contractSEC
10-K · Annual reportMar 28, 2024Annual reportSEC
SC 13G/A · Big-stake notice, amendedFeb 13, 2024Big-stake noticeSEC
8-K · Current reportFeb 6, 2024Material contractSEC
4 · Change in ownershipJan 12, 2024Insider tradeSEC
4 · Change in ownershipJan 3, 2024Insider tradeSEC
4 · Change in ownershipDec 18, 2023Insider tradeSEC
4 · Change in ownershipDec 11, 2023Insider tradeSEC
S-8 · Registration statement for employee plansNov 16, 2023Offer documentSEC
10-Q · Quarterly reportNov 13, 2023Quarterly reportSEC
4 · Change in ownershipSep 18, 2023Insider tradeSEC
4 · Change in ownershipSep 5, 2023Insider tradeSEC
4 · Change in ownershipAug 28, 2023Insider tradeSEC
4 · Change in ownershipAug 23, 2023Insider tradeSEC
10-Q · Quarterly reportAug 14, 2023Quarterly reportSEC
4 · Change in ownershipJul 28, 2023Insider tradeSEC
4 · Change in ownershipJul 28, 2023Insider tradeSEC
4 · Change in ownershipJul 28, 2023Insider tradeSEC
4 · Change in ownershipJul 28, 2023Insider tradeSEC
4 · Change in ownershipJul 28, 2023Insider tradeSEC
4 · Change in ownershipJul 28, 2023Insider tradeSEC
8-K · Current reportJul 20, 2023Current reportSEC
8-K · Current reportJul 19, 2023Meeting outcomeSEC
4/A · Change in ownership, amendedJul 10, 2023Insider tradeSEC
8-K/A · Current report, amendedJul 10, 2023Management or board changeSEC
DEFR14AJun 7, 2023Meeting noticeSEC
DEFA14A · Additional proxy materialJun 7, 2023Meeting noticeSEC
DEF 14A · Proxy statementJun 5, 2023Meeting noticeSEC
10-Q · Quarterly reportMay 12, 2023Quarterly reportSEC
4 · Change in ownershipMay 2, 2023Insider tradeSEC
3 · Initial statement of ownershipMay 2, 2023Insider tradeSEC
DApr 14, 2023Other filingsSEC
4 · Change in ownershipApr 12, 2023Insider tradeSEC
4 · Change in ownershipApr 10, 2023Insider tradeSEC
8-K · Current reportApr 10, 2023Management or board changeSEC
8-K · Current reportApr 6, 2023Material contractSEC
10-K · Annual reportMar 30, 2023Annual reportSEC
8-K · Current reportMar 14, 2023Management or board changeSEC
8-K · Current reportMar 7, 2023Material contractSEC
4 · Change in ownershipMar 2, 2023Insider tradeSEC
SC 13G/A · Big-stake notice, amendedFeb 16, 2023Big-stake noticeSEC
RW · Request to withdraw a registrationFeb 1, 2023Other filingsSEC
4 · Change in ownershipJan 27, 2023Insider tradeSEC
8-K · Current reportJan 26, 2023Management or board changeSEC
8-K · Current reportJan 12, 2023Management or board changeSEC
4 · Change in ownershipJan 5, 2023Insider tradeSEC
8-K · Current reportDec 28, 2022Current reportSEC
8-K · Current reportDec 23, 2022Current reportSEC
4 · Change in ownershipDec 9, 2022Insider tradeSEC
4 · Change in ownershipDec 9, 2022Insider tradeSEC
4 · Change in ownershipDec 9, 2022Insider tradeSEC
10-Q · Quarterly reportNov 14, 2022Quarterly reportSEC
8-K · Current reportNov 14, 2022ResultsSEC
S-1/A · Registration statement, amendedOct 27, 2022Offer documentSEC
8-K · Current reportOct 12, 2022Current reportSEC
8-K/A · Current report, amendedSep 20, 2022Meeting outcomeSEC
4 · Change in ownershipAug 9, 2022Insider tradeSEC
3 · Initial statement of ownershipAug 9, 2022Insider tradeSEC
8-K · Current reportAug 9, 2022Management or board changeSEC
10-Q · Quarterly reportAug 4, 2022Quarterly reportSEC
8-K · Current reportAug 4, 2022ResultsSEC
8-K · Current reportAug 2, 2022Meeting outcomeSEC
DEF 14A · Proxy statementJul 6, 2022Meeting noticeSEC
4 · Change in ownershipJul 1, 2022Insider tradeSEC
4 · Change in ownershipJul 1, 2022Insider tradeSEC
4 · Change in ownershipJul 1, 2022Insider tradeSEC
4 · Change in ownershipJul 1, 2022Insider tradeSEC
4 · Change in ownershipJul 1, 2022Insider tradeSEC
PRE 14A · Preliminary proxy statementJun 22, 2022Meeting noticeSEC
8-K · Current reportJun 22, 2022Meeting outcomeSEC
S-1 · Registration statementJun 21, 2022Offer documentSEC
SC 13G · Big-stake noticeJun 21, 2022Big-stake noticeSEC
8-K · Current reportJun 13, 2022FinancingSEC
DJun 8, 2022Other filingsSEC
4 · Change in ownershipMay 23, 2022Insider tradeSEC
4 · Change in ownershipMay 23, 2022Insider tradeSEC
4 · Change in ownershipMay 20, 2022Insider tradeSEC
4 · Change in ownershipMay 20, 2022Insider tradeSEC
4 · Change in ownershipMay 19, 2022Insider tradeSEC
10-Q · Quarterly reportMay 16, 2022Quarterly reportSEC
8-K · Current reportMay 16, 2022ResultsSEC
8-K · Current reportMay 13, 2022Material contractSEC
DEFA14A · Additional proxy materialMay 2, 2022Meeting noticeSEC
DEF 14A · Proxy statementMay 2, 2022Meeting noticeSEC
8-K · Current reportApr 28, 2022Material contractSEC
8-K · Current reportApr 1, 2022ResultsSEC
10-K · Annual reportMar 31, 2022Annual reportSEC
8-K · Current reportFeb 3, 2022Current reportSEC
8-K · Current reportJan 27, 2022Current reportSEC
4 · Change in ownershipJan 3, 2022Insider tradeSEC
4 · Change in ownershipJan 3, 2022Insider tradeSEC
8-K · Current reportDec 6, 2021Current reportSEC
4 · Change in ownershipNov 30, 2021Insider tradeSEC
3 · Initial statement of ownershipNov 30, 2021Insider tradeSEC
8-K · Current reportNov 30, 2021Material contractSEC
10-Q · Quarterly reportNov 15, 2021Quarterly reportSEC
8-K · Current reportNov 15, 2021ResultsSEC
4 · Change in ownershipNov 10, 2021Insider tradeSEC
4 · Change in ownershipNov 10, 2021Insider tradeSEC
4 · Change in ownershipNov 10, 2021Insider tradeSEC
4 · Change in ownershipNov 10, 2021Insider tradeSEC
4 · Change in ownershipNov 10, 2021Insider tradeSEC
3 · Initial statement of ownershipNov 10, 2021Insider tradeSEC
8-K · Current reportSep 24, 2021Current reportSEC
SC 13G · Big-stake noticeSep 23, 2021Big-stake noticeSEC
D/ASep 10, 2021Other filingsSEC
SC 13D/A · Big-stake notice, amendedSep 9, 2021Big-stake noticeSEC
4 · Change in ownershipSep 9, 2021Insider tradeSEC
8-K · Current reportSep 8, 2021Material contractSEC
10-Q · Quarterly reportAug 13, 2021Quarterly reportSEC
8-K · Current reportAug 13, 2021ResultsSEC
8-K · Current reportJul 9, 2021Current reportSEC
8-K · Current reportJun 28, 2021Meeting outcomeSEC
8-K · Current reportJun 24, 2021Current reportSEC
DJun 23, 2021Other filingsSEC
SC 13D/A · Big-stake notice, amendedJun 23, 2021Big-stake noticeSEC
8-K · Current reportJun 22, 2021Material contractSEC
4 · Change in ownershipJun 21, 2021Insider tradeSEC
8-K · Current reportMay 27, 2021Current reportSEC
10-Q · Quarterly reportMay 24, 2021Quarterly reportSEC
8-K · Current reportMay 24, 2021ResultsSEC
NT 10-Q · Late filing noticeMay 17, 2021Explanation requestSEC
3 · Initial statement of ownershipMay 4, 2021Insider tradeSEC
DEFA14A · Additional proxy materialApr 30, 2021Meeting noticeSEC
DEF 14A · Proxy statementApr 30, 2021Meeting noticeSEC
10-K · Annual reportApr 13, 2021Annual reportSEC
8-K · Current reportApr 13, 2021ResultsSEC
NT 10-K · Late filing noticeMar 31, 2021Explanation requestSEC
8-K · Current reportFeb 19, 2021Management or board changeSEC
8-K · Current reportFeb 4, 2021Management or board changeSEC
4 · Change in ownershipFeb 1, 2021Insider tradeSEC
3 · Initial statement of ownershipFeb 1, 2021Insider tradeSEC
8-K · Current reportJan 25, 2021Management or board changeSEC
8-K · Current reportDec 30, 2020Current reportSEC
10-Q · Quarterly reportNov 13, 2020Quarterly reportSEC
8-K · Current reportNov 13, 2020ResultsSEC
3 · Initial statement of ownershipNov 6, 2020Insider tradeSEC
8-K · Current reportOct 30, 2020Management or board changeSEC

This page holds 200 of 626 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Harvard Apparatus Regenerative Technology Inc’s releases

Common shares
20,284,471
Fully diluted
20,284,471

Fully diluted

LineShares
Common shares20,284,471

Share count over time

CountShares
Nov 22, 202620,284,471

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Jeffrey E Young
Other companies: Juniper Pharmaceuticals Inc (Chief Financial Officer · Jan 1, 2017 – Aug 14, 2018 · Past); Tempest Therapeutics, Inc. (Chief Financial Officer · Sep 8, 2014 – Dec 3, 2015 · Past)
Director · Nov 6, 2018 – Jun 25, 2020 · Past
John J Canepa
Other companies: Candel Therapeutics, Inc. (Chief Financial Officer · Jul 26, 2021 – Feb 28, 2022 · Past)
Director · Oct 16, 2013 – Mar 14, 2018 · Past
Ronald J Packard
Other companies: Stride, Inc. (Chief Executive Officer, Director · Mar 28, 2013 – Dec 31, 2013 · Past)
Director · Since at least Apr 5, 2023
David GreenDirector · Since at least Nov 5, 2026
Herman SanchezDirector · Since at least Jan 19, 2021
Hong YuPresident · Since at least Nov 5, 2026
James Joseph McGorryChief Executive Officer, Director · Oct 16, 2013 – Jun 12, 2018 · Past
James MastridgeSee Remarks · Oct 29, 2020 – Oct 29, 2020 · Past
James ShmerlingDirector · Since at least Jun 27, 2025
Jason Jing ChenVice Chairman · Since at least Nov 5, 2026
All 23 people
PersonSeat
Jerry HeCEO · Since at least Nov 4, 2026
Jing ChenDirector · Since at least Feb 6, 2018
Joseph DamasioChief Financial Officer · Since at least Nov 5, 2026
Junli HeCEO, Director · Since at least Sep 1, 2021
Mao ZhangDirector · Since at least Aug 26, 2024
Peter A PellegrinoInterim VP of Finance · Apr 8, 2021 – Apr 8, 2021 · Past
Peter M ChakoutisVice President of Finance · Aug 8, 2019 – May 14, 2020 · Past
Ron PackardDirector · Since at least Nov 4, 2026
Saverio LaFrancescaPresident and CMO, Director · Apr 29, 2015 – Aug 24, 2017 · Past
Shunfu HuVP of Business Development and Operations · Since at least Nov 5, 2026
Thomas McNaughtonChief Financial Officer · Jun 14, 2019 – Jun 14, 2019 · Past
Ting LiDirector · Since at least Nov 5, 2026
William FodorChief Scientific Officer · Since at least Mar 23, 2018

Open People

Log in to ask 6ix AI your own questions about Harvard Apparatus Regenerative Technology Inc.